Kestra Medical Technologies, Ltd. Increase (Decrease) in Prepaid Expense and Other Assets
Kestra Medical Technologies, Ltd. (KMTS) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$246.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-07-31 was -$246.00K.
- Kestra Medical Technologies, Ltd. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-04-30 was $984.00K, a 30.75% decline year-over-year.
- Kestra Medical Technologies, Ltd. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-01-31 was $532.00K, a 40.74% increase year-over-year.
- Kestra Medical Technologies, Ltd. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-10-31 was -$813.00K.
- Kestra Medical Technologies, Ltd. increase (decrease) in prepaid expense and other assets for fiscal 2026 was $563.00K, a 69.60% decline from fiscal 2025.
- Kestra Medical Technologies, Ltd. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.85M.
- Kestra Medical Technologies, Ltd. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$331.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$246.00K 10-Q · filed 2026-09-14 | $738.00K derived: sum of 2 quarters · filed 2026-09-14 | $1.27M derived: sum of 3 quarters · filed 2026-09-14 | $457.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $984.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $1.52M derived: sum of 2 quarters · filed 2026-07-14 | $703.00K derived: sum of 3 quarters · filed 2026-07-14 | $563.00K 10-K · filed 2026-07-14 |
| 2026-01-31 | $532.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -$281.00K derived: sum of 2 quarters · filed 2026-03-17 | -$421.00K 10-Q · filed 2026-03-17 | $1.00M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | -$813.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | -$953.00K 10-Q · filed 2025-12-11 | $468.00K derived: sum of 3 quarters · filed 2026-09-14 | $846.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | -$140.00K 10-Q · filed 2026-09-14 | $1.28M derived: sum of 2 quarters · filed 2026-09-14 | $1.66M derived: sum of 3 quarters · filed 2026-09-14 | $1.32M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $1.80M derived: sum of 2 quarters · filed 2026-07-14 | $1.46M derived: sum of 3 quarters · filed 2026-07-14 | $1.85M 10-K · filed 2026-07-14 |
| 2025-01-31 | $378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $42.00K derived: sum of 2 quarters · filed 2026-03-17 | $431.00K 10-Q · filed 2026-03-17 | |
| 2024-10-31 | -$336.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | $53.00K 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $389.00K 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | -$331.00K 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |